Ann: Exopharm LEAP Technology - Second Commercial Collaboration, page-6

What a joke.
$10k upfront and a few monthly payments of $5k? Is this the best they can do? Gee, Showa Denko must really be DESPERATE to get their hands on this pixie dust technology (BTW, that is sarcasm).
A "leader in regenerative medicine". Really? Doesn't even appear on their website.
Thanks Dr Dixon for the quote. At least now we know the monetary value of "....a good way to de-risk a potential future commercial use of our LEAP technology to purify exosomes".
And to have the affront to mention the Finnish Red Cross Blood Service "deal" which appears to have not proceeded beyond an MoU.